Express Scripts, the nation’s largest pharmacy benefits manager, will limit the number and strength of opioid drugs prescribed to first-time users starting in September 2017 as part of a wide ...

Express Scripts Holding Co. said Monday it will no longer cover Sovaldi and Harvoni from Gilead Sciences Inc. or Johnson & Johnson’s Olysio starting Jan. 1, except under limited circumstances.